Actuate Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Actuate Therapeutics shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Actuate Therapeutics by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $25k | 3.4k | 7.45 |